THE BIOLOGICAL ACTIVITY OF PLANT-DERIVED ANTI-HER2 RECOMBINANT ANTIBODIES


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Pharmaceuticals derived from plants, have become one of the leading commercial directions in modern biotechnology. The benefits that offer these technologies, cannot be matched with any other modern technology for producing drugs from recombinant proteins. Main advantages of plant technologies for production of proteins are easy scalability, efficiency, bio-safety, ease of cultivation and collection of biological material. This approach promises to be the most perspective for production of a wide range of drug substances and vaccines. In current investigation we have analyzed in vitro and in vivo biological activity of plant-derived anti-HER2 recombinant antibodies - phytotrastuzumab. Phytotrastuzumab and trastuzumab have similar activity in grows suppression of breast cancer cells overexpressing HER2 in-vitro and were active in suppression of xenografted tumors SK-BR-3 in-vivo.

About the authors

V. S. Kosorukov

ФГБУ «РОНЦ им. Н.Н.Блохина»

Author for correspondence.
Email: atgtga@mail.ru
Russian Federation

E. N. Kosobokova

ФГБУ «РОНЦ им. Н.Н.Блохина»

Russian Federation

M. V. Pinyugina

ФГБУ «РОНЦ им. Н.Н.Блохина»

Russian Federation

M. A. Sevostyanova

ФГБУ «РОНЦ им. Н.Н.Блохина»

Russian Federation

A. I. Scherbakov

ФГБУ «РОНЦ им. Н.Н.Блохина»

Russian Federation

N. V. Andronova

ФГБУ «РОНЦ им. Н.Н.Блохина»

Russian Federation

E. Sh. Solomko

ФГБУ «РОНЦ им. Н.Н.Блохина»

Russian Federation

E. V. Sheshukova

Московский государственный университет им. М.В. Ломоносова

Russian Federation

E. M. Treschalina

ФГБУ «РОНЦ им. Н.Н.Блохина»

Russian Federation

Yu. L. Dorokhov

Московский государственный университет им. М.В. Ломоносова

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c)



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-53039 от  04.03.2013.